BREAKING: New study finds HCQ +AZ (or other antibiotic) significantly reduces time to viral clearance and hospital stay in moderate covid-19 patients compared to both conservative treatment and Lopinavir-ritonavir.https://t.co/FnCpMhy2R0 pic.twitter.com/fTVpVAsERB
— Hydroxychloroquine News (@niro60487270) May 19, 2020
Investigation of Surgisphere by data scientist @ellis2013nz
— James Todaro, MD (@JamesTodaroMD) May 30, 2020
"the data represents treatment and health outcomes of 96,032 patients from 671 hospitals in six continents...there is simply no plausible way I can think of that the data are real."#LancetGate https://t.co/2ziesbagGb
Questions persist about Surgisphere, the company that produced the Lancet study that resulted in the halting of HCQ use for Covid-19 around the world.https://t.co/yPbjMZlbGk
— Hydroxychloroquine News (@niro60487270) May 31, 2020
The Lancet study on hydroxychloroquine is going down in flames. 🔥 🔥🔥
— James Todaro, MD (@JamesTodaroMD) May 29, 2020
Remember the WHO halted hydroxychloroquine trials worldwide over this study, after reviewing the data for a mere 48-72 hours over a weekend.
No comments:
Post a Comment